Target intelligence / Profile preview

Vascular Endothelial Growth Inhibitor (VEGI)

Target
VEGI
Molecular classification
Cytokine, TNF superfamily ligand
01

Overview

Vascular Endothelial Growth Inhibitor (VEGI), also known as TNFSF15 or TL1A, is a cytokine that belongs to the TNF superfamily. It functions as an anti-angiogenic factor by inhibiting the proliferation of endothelial cells and suppressing angiogenesis. VEGI plays a role in modulating immune responses and vascular development, and it has been implicated in the pathogenesis of inflammatory diseases. As a cytokine, there is potential for immune-related adverse events.

Other names
TNFSF15TL1A
02

Mechanism of action

Inhibits endothelial cell proliferation and angiogenesis through interactions with its receptor.

03

Biological functions

Inhibition of angiogenesisSuppression of endothelial cell proliferationModulation of immune responsesRegulation of vascular development
04

Disease associations

Inflammatory diseasesCancerAutoimmune disorders
05

Safety considerations

Potential for immune-related adverse events due to cytokine activity.

Beyond the preview

Go deeper on Vascular Endothelial Growth Inhibitor (VEGI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vascular Endothelial Growth Inhibitor (VEGI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call